PANK2 Gene Pantothenate kinase-associated neurodegeneration Genetic Test
Test Name: PANK2 Gene Pantothenate kinase-associated neurodegeneration Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test Type: Neurological Disorders
Doctor: Neurologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for PANK2 Gene Pantothenate kinase-associated neurodegeneration NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PANK2 Gene Pantothenate kinase-associated neurodegeneration.
Test Details
The PANK2 gene is responsible for encoding the pantothenate kinase 2 enzyme, which plays a crucial role in the production of coenzyme A (CoA). CoA is essential for various cellular processes, including the metabolism of fatty acids and the synthesis of neurotransmitters.
Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic disorder caused by mutations in the PANK2 gene. This condition leads to the progressive degeneration of the nervous system, resulting in movement abnormalities, cognitive decline, and other neurological symptoms.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of an individual. It allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of PKAN, NGS genetic testing can be used to identify mutations in the PANK2 gene, providing a definitive diagnosis for affected individuals.
NGS genetic testing for PKAN typically involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the PANK2 gene.
This genetic test can help confirm a diagnosis of PKAN and provide valuable information for genetic counseling, family planning, and potential treatment options. It can also be used for carrier testing in individuals with a family history of PKAN to determine their risk of passing on the condition to their children.
| Test Name | PANK2 Gene Pantothenate kinase-associated neurodegeneration Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for PANK2 Gene Pantothenate kinase-associated neurodegeneration NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PANK2 Gene Pantothenate kinase-associated neurodegeneration |
| Test Details |
The PANK2 gene is responsible for encoding the pantothenate kinase 2 enzyme, which plays a crucial role in the production of coenzyme A (CoA). CoA is essential for various cellular processes, including the metabolism of fatty acids and the synthesis of neurotransmitters. Pantothenate kinase-associated neurodegeneration (PKAN) is a rare genetic disorder caused by mutations in the PANK2 gene. This condition leads to the progressive degeneration of the nervous system, resulting in movement abnormalities, cognitive decline, and other neurological symptoms. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze the DNA sequence of an individual. It allows for the simultaneous sequencing of multiple genes or even the entire genome. In the case of PKAN, NGS genetic testing can be used to identify mutations in the PANK2 gene, providing a definitive diagnosis for affected individuals. NGS genetic testing for PKAN typically involves obtaining a DNA sample, usually through a blood or saliva sample, from the individual being tested. The DNA is then sequenced using NGS technology, and the resulting data is analyzed to identify any mutations or variations in the PANK2 gene. This genetic test can help confirm a diagnosis of PKAN and provide valuable information for genetic counseling, family planning, and potential treatment options. It can also be used for carrier testing in individuals with a family history of PKAN to determine their risk of passing on the condition to their children. |
